Related by context. All words. (Click for frequent words.) 70 BRCA mutation 69 colorectal neoplasia 69 BRCA mutations 68 BRCA2 mutations 67 BRCA1 mutations 67 advanced neoplasia 67 BRCA2 carriers 66 oophorectomy 66 BRCA2 mutation 66 slow metabolizers 64 atypical hyperplasia 64 BRCA carriers 64 BRCA2 mutation carriers 64 nonpregnant women 64 premenopausal breast cancer 63 BRCA1 mutation carriers 63 BRCA gene mutation 63 prophylactic mastectomies 62 BRCA1 mutation 62 salpingo oophorectomy 62 placental malaria 62 BRCA2 gene mutation 62 endometrial cancers 62 subclinical hyperthyroidism 62 testosterone supplementation 61 ApoE4 gene 61 preventive mastectomy 61 parous women 61 recurrent miscarriages 61 contralateral breast cancer 61 dizygotic twins 61 nondepressed 61 shorter telomeres 60 bilateral oophorectomy 60 polycystic ovary syndrome PCOS 60 familial pancreatic cancer 60 faulty BRCA2 gene 60 abnormal mammograms 60 coronary calcification 60 advanced adenomas 60 prophylactic mastectomy 60 TT genotype 60 breast cancer gene mutation 60 denser breasts 60 asymptomatic hypothyroidism 60 beta carotene supplementation 60 poor metabolizers 59 abnormal Pap test 59 benign breast 59 recurrent UTI 59 monozygotic 59 ELBW infants 59 chromosomal disorders 59 premature menopause 59 NNRTI resistance 59 spontaneous preterm delivery 59 advanced adenoma 59 bowel polyps 59 pre menopausal 59 singleton babies 59 gestational diabetes mellitus 59 narcolepsy cataplexy 59 KRAS mutations 59 menopausal hormone therapy 59 mutated BRCA1 59 folate intake 59 fasting triglyceride levels 59 telomere lengths 59 hormone therapy estrogen 58 irregular menstrual cycles 58 cerebral microbleeds 58 postnatally 58 SE alleles 58 postmenopausal breast cancer 58 endometrial carcinoma 58 undergone hysterectomies 58 subfertile 58 premenopausal 58 undergone hysterectomy 58 drank colas 58 chlamydial infection 58 anovulatory infertility 58 dietary calcium intake 58 Leitzmann 58 mild gestational diabetes 58 APOE ε4 58 BRCA1 gene mutation 58 faulty BRCA genes 58 hydroxyvitamin D levels 58 Epidemiologic studies 58 bowel cancers 58 BRCA1 58 lobular cancer 58 polycystic ovarian syndrome PCOS 58 Postpartum depression affects 58 elevated depressive symptoms 58 estrogen progestin therapy 58 folate supplementation 58 nulliparous women 58 delaying childbirth 58 waist circumferences 57 symptomatic fibroids 57 GnRH agonists 57 normal birthweight 57 subclinical hypothyroidism 57 born preterm 57 precancerous polyp 57 dizygotic 57 malignant polyps 57 abnormal glucose tolerance 57 preterm deliveries 57 hormone blockers 57 singleton pregnancies 57 hsCRP levels 57 nonmelanoma skin cancers 57 PSA velocity 57 HIV HCV coinfected 57 preventive mastectomies 57 elevated CRP 57 fibroids endometriosis 57 acrylamide intake 57 varicocele 57 probands 57 Fragile X gene 57 unexplained infertility 57 singleton pregnancy 57 asymptomatic PAD 57 sigmoidoscopies 57 baseline HbA1c 57 serum selenium 57 postmenopausal hormones 57 tanned indoors 57 perimenopausal women 57 colorectal neoplasms 57 extracolonic findings 57 PSA screening 57 cryptorchidism 57 beta carotene supplements 57 nondrinkers 57 lobular breast cancer 57 plasma homocysteine levels 57 colorectal polyps 57 serum creatinine levels 57 CHD mortality 57 uterine cancers 57 renal cell carcinomas 57 abnormal Pap smears 57 pCR 57 adenomatous polyps 57 noncarriers 56 alpha carotene 56 testicular germ cell 56 undergone radical prostatectomy 56 BRCA testing 56 basal cell nevus syndrome 56 intravenous bisphosphonates 56 estrogen receptor negative 56 operable breast cancer 56 drank pomegranate juice 56 congenital abnormalities 56 thyroid hormone levels 56 Munk Olsen 56 abdominal ultrasounds 56 endometriosis ovarian cysts 56 Rectal cancer 56 nonmelanoma skin cancer 56 colorectal adenomas 56 cohabiting relationships 56 uncomplicated pregnancies 56 thyrotropin levels 56 seropositivity 56 Complication rates 56 nonfasting triglyceride levels 56 underwent brachytherapy 56 APOE e4 gene 56 Multivariate analyzes 56 Premenopausal women 56 endometrial cancer 56 HNPCC 56 non aspirin NSAIDs 56 typical antipsychotics 56 postmenopausal hormone therapy 56 calcium intakes 56 dysglycemia 56 Cochrane reviewers 56 BRCA mutation carriers 56 Adjuvant chemotherapy 56 undergone bariatric surgery 56 TCF#L# gene 56 infantile hemangiomas 56 premenopausal women 56 TGFBR1 * 6A 56 colorectal cancer incidence 56 Personality traits 56 dietary fiber intake 56 familial aggregation 56 Breastfed babies 56 colorectal polyp 56 fraternal twin pairs 56 adiponectin levels 56 precancer 56 lymph node removal 56 recurrent VTE 56 folic acid intake 56 ApoE4 allele 56 deCODE BreastCancer TM 56 MetS 55 benign growths 55 recurrent miscarriage 55 perioperative complications 55 ovulation induction 55 elective caesarean section 55 HER2 positive cancers 55 carotid stenosis 55 choline intake 55 azoospermia 55 2D 4D ratio 55 paternal discrepancy 55 polycystic ovaries 55 carotid plaques 55 HER2 positive tumors 55 ductal breast cancer 55 hereditary breast cancer 55 undergoing hysterectomy 55 Schaffir 55 genes BRCA1 55 CC genotype 55 APOE e4 55 normal littermates 55 invasive carcinoma 55 Health Initiative Observational 55 chorioamnionitis 55 thrombophilia 55 colorectal adenoma 55 anal cancers 55 transferrin saturation 55 testicular tumors 55 VUR 55 serum concentrations 55 CVD mortality 55 Alvergne 55 proband 55 multivariate analyzes 55 BRCA1 gene 55 Caesarean deliveries 55 mammographic screening 55 obstetric interventions 55 familial clustering 55 fetal malformations 55 postoperative complications 55 nondemented 55 breastfed exclusively 55 shorter telomere length 55 MMSE scores 55 atypical ductal hyperplasia 55 prostates removed 55 tibolone 55 preterm delivery 55 undergoing bariatric surgery 55 autistic traits 55 unhealthier lifestyles 55 plasma folate 55 triacylglycerol concentrations 55 A. Beydoun 55 HIV uninfected 55 Ovary removal 55 prostate cancer CaP 55 Subgroup analyzes 55 underwent radical prostatectomy 55 Postnatal depression 55 breast endometrial 55 gallstone disease 55 inherited mutations 55 confidence interval #.#-#.# 55 nonpregnant 55 chlamydia infection 55 #q# deletion 55 premature ovarian 55 endometrial thickness 55 drank decaffeinated coffee 55 Multiple logistic regression 55 undescended testicles 55 prostate pancreatic 55 ovulatory infertility 55 polycystic ovary syndrome 55 Baseline characteristics 55 underwent bariatric surgery 55 postmenopausal hormone replacement 55 arterial thickening 55 retrospective cohort 55 colon tumors 55 nulliparous 55 axillary node dissection 55 Triglyceride levels 55 K ras mutations 55 obese adolescents 55 PCA3 scores 55 tamoxifen therapy 55 polyp recurrence 54 neurological abnormalities 54 sigmoidoscopy 54 V Leiden 54 subfertility 54 gestational hypertension 54 AMOR IPAT 54 cranial irradiation 54 Fatty Liver Disease 54 oral bisphosphonates 54 lipid lowering therapy 54 nondiabetic 54 ovulatory cycles 54 Moderate drinkers 54 pre eclamptic 54 Radical prostatectomy 54 FTO variant 54 CHDs 54 metabolically healthy 54 primary ovarian insufficiency 54 neurodevelopmental outcomes 54 intensive statin therapy 54 psychiatric comorbidities 54 glioma tumors 54 serum estradiol 54 bilateral prophylactic mastectomy 54 intestinal polyps 54 CIN3 54 ovary removal 54 neurologic complications 54 cosmetic breast implants 54 folate deficiency 54 estrogen progestin combination 54 socioeconomic status SES 54 cesarean deliveries 54 gestational diabetes mellitus GDM 54 penetrance 54 postmenopausal hormone 54 FeNO 54 GBA mutations 54 endogenous estrogen 54 transfusion syndrome 54 T1DM 54 RLS sufferers 54 prenatally diagnosed 54 postoperative mortality 54 nonobese 54 spontaneous preterm births 54 statin medications 54 prime childbearing 54 axillary lymph nodes 54 microscopic colitis 54 unmeasured factors 54 endometrial hyperplasia 54 penile sensitivity 54 serum lipid levels 54 vaginal hysterectomy 54 chromosomal abnormalities 54 monozygotic twins 54 dietary folate intake 54 oral contraceptive pills 54 hematopoietic cancers 54 cohabitors 54 renal tumors 54 screening colonoscopy 54 breast cancer genes BRCA1 54 diverticular bleeding 54 relapsed MM 54 GSTM1 gene 54 BRCA2 gene mutations 54 HIV seronegative 54 aldosterone antagonist 54 cervical lesions 54 Kozyrskyj 54 ovarian hyperstimulation syndrome OHSS 54 orofacial clefts 54 prescribed statins 54 abnormal cytology 54 cesarean births 54 serum vitamin D 54 Swedish Mammography Cohort 54 newer antipsychotics 54 lymph node involvement 54 adenoma 54 HER2 expression 54 habitual snorers 54 HbA1C levels 54 neutrophil counts 54 extracolonic 54 definite stent thrombosis 54 haemorrhagic stroke 54 carotid plaque 54 underwent CABG 54 thigh circumference 54 abnormal Pap smear 54 Subclinical hypothyroidism 54 Women 54 varicoceles 54 calcium supplementation 54 adolescent females 54 baseline mammogram 54 NHANES III 54 sleeve lobectomy 54 benign nodules 54 prostate carcinoma 54 mammographic density 54 univariate analysis 54 ICDs implanted 54 androgen deprivation 54 fetal chromosomal 53 seminoma 53 Heavy menstrual bleeding 53 Suicidal tendencies 53 BRCA 53 plusers 53 preterm babies 53 genital HPV infections 53 CIN2 + 53 female endoscopist 53 multiple gestations 53 elevated hsCRP 53 mammary tumors 53 BRCA genes 53 leiomyomas 53 venlafaxine Effexor 53 thyroid cancers 53 spontaneous preterm birth 53 APOE4 53 serum testosterone levels 53 distal colon cancer 53 invasive ductal 53 venous thrombosis 53 vaccinees 53 lipid lowering medications 53 pre cancerous polyps 53 Thyroid nodules 53 breast conserving 53 C#Y 53 germline mutations 53 sulphonylureas 53 preoperative chemotherapy 53 internalizing disorders 53 BMI percentile 53 serous ovarian cancer 53 delaying childbearing 53 parous 53 heterozygotes 53 Vitamin D supplements 53 premenopause 53 undergo radical prostatectomy 53 GIST tumors 53 ApoE4 53 selenium intake 53 multivariable adjusted 53 uterine perforation 53 SHBG levels 53 menthol smokers 53 Uterine fibroids 53 Michael F. Leitzmann 53 hormone receptor negative 53 monozygotic twin 53 HNSCC 53 #q#.# deletion syndrome 53 urolithiasis 53 ovarian hormones 53 contralateral breast 53 EGFR mutations 53 perinatal outcomes 53 Li Fraumeni 53 carotid IMT 53 invasive ductal breast cancer 53 serum PSA 53 PCa 53 Uterine cancer 53 nonselective NSAIDs 53 psychiatric outpatients 53 clinically insignificant 53 cesareans 53 vertebral fracture 53 undergoing radical prostatectomy 53 lipid lowering drugs 53 VLBW 53 UGT#A# * 53 Breastfed infants 53 ticlopidine 53 GSTM1 53 TP# mutation 53 prostate glands 53 adjuvant radiotherapy 53 hormone receptor status 53 CARDIA 53 difficulty conceiving 53 poorer prognosis 53 bladder cancers 53 familial predisposition 53 aneuploid cells 53 liver transplant recipients 53 elective caesarean sections 53 nodal metastases 53 antenatal depression 53 untreated celiac disease 53 prepregnancy 53 Karin Michels 53 androgen excess 53 abnormal mammogram 53 prostate specific 53 tuberculin skin testing 53 loop diuretics 53 breech births 53 kidney transplant recipients 53 nonsurgical treatments 53 genetic variants associated 53 ovarian tumors 53 depressive symptoms 53 DayQuil capsules 53 epigenetic changes 53 Unwed mothers 53 TACI mutations 53 ambiguous genitalia 53 platonic friendships 53 colorectal tumors 53 undergo prostate biopsy 53 heterozygous 53 tumor histology 53 ovarian cancers 53 chronic prostatitis 53 noncancer 53 paternal lineages 53 BLLs 53 Hurthle cell 53 herpes infection 53 Chlamydia infection 53 polypoid lesions 53 Colon polyps 53 APOE genotype 53 virologic failure 53 BRCA2 genetic mutations 53 fasting glucose levels 53 deliver vaginally 53 Premenopausal 53 vaginal progesterone gel 53 oncologic outcomes 53 nonvertebral fractures 53 undergo bariatric surgery 53 untreated hypothyroidism 53 undergo mastectomy 53 antihypertensive medications 53 macrosomia 53 BCG vaccinated 53 lymphatic cancers 53 androgen suppression 53 nonparents 53 severe periodontitis 53 nephron sparing surgery 53 thiazide diuretics 53 comorbid conditions 53 basal cell cancers 53 ε4 53 univariate analyzes 53 ovarian stimulation 52 ovarian endometrial 52 atypia 52 asymptomatic carotid stenosis 52 abnormal lipid levels 52 armpit lymph nodes 52 ovaries removed 52 hypospadias 52 nonpregnant adults 52 colon rectal 52 homozygotes 52 SLNB 52 adjunctive ABILIFY 52 Pischon 52 elevated LDL cholesterol 52 artery calcification 52 breastfed infants 52 oropharyngeal cancer 52 Newschaffer 52 pathologic fractures 52 Bobbitt Zeher 52 Dr Zorbas 52 ICSI cycles 52 precancerous tumors 52 metastatic prostate 52 multivariate adjustment 52 postoperative chemotherapy 52 AVODART 52 ALT flares 52 precancerous colon polyps 52 SRBD 52 hereditary predisposition 52 dose ionizing radiation 52 IUGR 52 serum testosterone 52 non pledgers 52 genital tract infections 52 carbohydrate intolerance 52 A1Cs 52 ASCUS 52 HER2 overexpression 52 invasive prenatal 52 umol L 52 colorectal bowel 52 comorbid disorders 52 ductal cancer 52 postoperative delirium 52 lignan intake 52 perioperative morbidity 52 ELBW 52 Doubeni 52 obstetric complications 52 Testicular cancer 52 post menopausal 52 adenomas 52 Flexi Scope 52 congenital toxoplasmosis 52 eribulin 52 multivariable analysis 52 differentially expressed genes 52 Gestational diabetes affects 52 chromosomal anomalies 52 familial hypercholesterolemia 52 placenta praevia 52 diagnosed prenatally 52 phytoestrogen intake 52 VLBW infants 52 FREE HEARING SCREENING 52 subgroup analyzes 52 nonadherence 52 BMPR2 52 neoplasias 52 dietary intakes 52 basal cell carcinomas 52 magnesium intake 52 chromosomal alterations 52 hypoglycemic episodes 52 chlorthalidone 52 oestradiol 52 aged ≥ 52 CLA supplementation 52 % CI #.#-#.# [003] 52 undergo lumpectomy 52 psychiatric comorbidity 52 spine fractures 52 TEAEs 52 serum uric acid 52 genital HPV infection 52 microscopic hematuria 52 seroconverted 52 Vitamin D deficient 52 EGFR mutation 52 Netherlands Cohort Study 52 limb sparing 52 habitual snoring 52 endoscopic examinations 52 Regular checkups 52 FGFR2 gene 52 IDs Digal 52 PSADT 52 sociodemographic characteristics 52 low birthweight infants 52 lung adenocarcinoma 52 A1 gene variant 52 iodine intake 52 conventional angiography 52 antigen PSA 52 Observational studies 52 menarche 52 methodological limitations 52 cisplatin chemotherapy 52 GBV C 52 hamartomas 52 preintervention 52 Hilakivi Clarke 52 genital ulcer disease 52 femoral neck BMD 52 preeclamptic 52 AAT deficiency 52 premenstrual syndrome PMS 52 osteosarcomas 52 vasomotor symptoms 52 behavioral disinhibition 52 latent TB infection 52 frequently benign tumor 52 mammographically 52 mIU ml 52 insecurely attached 52 conditional logistic regression 52 folate intakes 52 serum IGF 52 malignant lesions 52 estrogen metabolites 52 statin cholesterol lowering 52 multivitamin supplements 52 serodiscordant couples 52 adjuvant radiation 52 congenital malformations 52 detectable BPA 52 cystatin C 52 osteopenic 52 hyperemesis gravidarum 52 apolipoprotein E4 52 benign lesions 52 ALND 52 NLSY 52 ultra rapid metabolizer 52 abnormal growths 52 prepubertal 52 prepregnancy BMI 52 sentinel nodes 52 nonexposed 52 lifetime abstainers 52 Prostatitis 52 pyloric stenosis 52 valproate 52 incomplete revascularization 52 urinary tract symptoms 52 ovarian hyperstimulation 52 AUDs 52 breast cancer recurrence 52 Genetic variants 52 antihypertensive medication 52 DHEA supplementation 52 Cesarean delivery 52 HIV seropositive 52 suppressing menstruation 52 subclinical atherosclerosis 52 Migraineurs 52 endarterectomy 52 EUS FNA 52 highest quintile 52 BRAF mutations 52 lobular involution 52 HPV genotypes 52 breast tenderness 52 Postmenopausal 52 Wisconsin Sleep Cohort 52 ASD prevalence 52 dose statin therapy 52 folic acid supplement 52 hepatectomy 52 breast cancer recurrences 52 fibrocystic disease 51 curable cancers 51 birthweight 51 breast asymmetry 51 antioxidant supplementation 51 miscarriages stillbirths 51 MGUS 51 genotypic resistance 51 hormone deprivation 51 progesterone receptor negative 51 biochemical relapse 51 sCJD 51 testicular cancers 51 distant metastases 51 CR nPR 51 HLA gene variant 51 digital rectal examination 51 airway responsiveness 51 tamoxifen Nolvadex ® 51 serum IgE 51 PBDE chemicals 51 CARDIA study 51 HbA 1c levels 51 lipid abnormalities 51 heavily pretreated 51 cotinine levels 51 nodal metastasis 51 radical nephrectomy 51 flavonoid intake 51 fewer uterine cancers 51 Premature menopause 51 IgA deficiency 51 unipolar depression 51 enamel defects 51 metabolic syndrome MetS 51 β blockers 51 adnexal mass 51 KIF6 carriers 51 nondiabetics 51 breast carcinoma 51 recurrent tonsillitis 51 HGPIN 51 #.#ng/ml 51 Winkelmayer 51 prophylactic oophorectomy 51 perioperative mortality 51 pg ml 51 corticosterone levels 51 LUTS 51 incidentalomas 51 CCR5 delta# 51 de ath 51 Framingham Offspring Study 51 % CI #.#-#.# [008] 51 hepatitis C genotype 51 Fanconi syndrome 51 limiting generalizability 51 TP# mutations 51 urinary cortisol 51 grade gliomas 51 malignant neoplasm 51 vasectomy reversals 51 postoperative morbidity 51 neural tube birth defects 51 cystectomy 51 BRCA2 gene 51 FUS protein 51 thyroid nodules 51 BMD measurements 51 fibrate drugs 51 dietary questionnaires 51 breast cancers 51 tamoxifen raloxifene 51 URTI 51 Prostate Lung Colorectal 51 perioperatively 51 USPSTF recommends 51 Vitamin B# deficiency 51 fast metabolizers 51 super recognizers 51 Postmenopausal women 51 asymptomatic bacteriuria 51 trans palmitoleic acid 51 anogenital distance 51 immunosuppressive medications 51 Ovarian cysts 51 Wactawski Wende 51 atypical antipsychotic medications 51 androgen deficiency 51 precancers 51 undescended testes 51 abdominally obese 51 atypical fractures 51 spontaneous miscarriages 51 nonfasting 51 Childlessness 51 periodontal gum disease 51 carry BRCA mutation 51 endogenous hormones 51 CDH1 51 Eric Rimm 51 mammary gland tumors 51 hippocampal volume 51 stomachs stapled 51 nonrandomized studies 51 nondiabetic patients 51 KRAS status 51 Morbidly obese patients 51 DCIS lesions 51 BRAC2 51 liver metastasis 51 tubal reversal 51 serum urate levels 51 unwed births 51 newer atypical antipsychotics 51 gene variant 51 daytime naps 51 screening colonoscopies 51 elevated triglyceride levels 51 postoperative infections 51 gastrectomy 51 vitamin D inadequacy 51 folate supplements 51 Fatalistic kids 51 virologic responses 51 pyelonephritis 51 axillary dissection 51 congenital CMV 51 multivariate logistic regression 51 triplet pregnancies 51 brain lesions 51 puzzling paradox 51 beta blocker therapy 51 genetic abnormalities 51 endoscopists 51 underactive thyroids 51 thalassemia trait 51 unneeded biopsies 51 nonmarital births 51 coronary angiograms 51 underwent prostatectomy 51 surveyed PCPs 51 serum folate 51 bilirubin levels 51 Hormone pills 51 conventional antipsychotics 51 nonhereditary 51 Logistic regression 51 homocysteine concentrations 51 gestational glucose intolerance 51 liver biopsies 51 Goltz syndrome 51 CDKN2A 51 genetic predisposition 51 anovulatory 51 biochemical recurrence 51 vaginal deliveries 51 molar pregnancy 51 precursor lesions 51 consanguineous marriages 51 rates Tangka 51 atrophic gastritis 51 comorbidities 51 calorie diets 51 Colorectal cancer screening 51 atopic 51 urinary bladder cancer 51 neurodevelopmental impairment 51 APOE4 gene 51 paternally inherited 51 chlamydial infections 51 induce ovulation 51 PTEN mutations 51 selenium supplementation 51 urinary symptoms 51 colorectal cancer CRC 51 Framingham Offspring 51 locoregional recurrence 51 nonmarried 51 mutated genes 51 Sylvia Wassertheil Smoller 51 anticonvulsant medications 51 ruptured aneurysms 51 pancreatic adenocarcinoma 51 estrogen pills 51 Randomized trials 51 axillary node 51 GABRA2 51 extrapyramidal symptoms 51 precancerous cervical 51 CYP#C# [001] 51 yearly mammograms 51 conjugated equine estrogen 51 recurrent ischemic stroke 51 comorbidity 51 mutant allele 51 neurocognitive impairment 51 ALDH2 deficient 51 #mg/dL [001] 51 undiagnosed celiac disease 51 Anal cancer 51 cervical abnormalities 51 white matter hyperintensities 51 trivial Klatsky 51 gene variants 51 seminomas 51 anthracycline therapy 51 oncogenic HPV 51 epithelial ovarian cancer 51 Screening mammograms 51 paclitaxel eluting stents 51 atypical nevi 51 PLUS LIFELONG FITNESS 51 hormone therapy HT 51 MYH9 gene 51 gene variation 51 prostate cancers 51 Amniocentesis 51 abnormal lipid 51 allele frequencies 51 Patricia Buffler 51 fetuin 51 genetic variant 51 fluvastatin 51 irregular menstrual periods 51 NPH insulin 51 Kaplan Meier analysis 51 Relapsing remitting MS 51 breast lumps 51 mammary cancers 51 Liver transplants 51 GH deficiency 51 bisphosphonate drugs 51 awaiting kidney transplants 51 prolactin levels 51 phthalate metabolites 51 hormonal therapy 51 LTBI 51 gene BRCA2 51 mild analgesics 51 GBM tumors 51 HCV infected 51 Stuttering tends 51 diffuse gastric 50 rectal gonorrhea 50 inhaled budesonide 50 comorbid illnesses 50 mosaicism 50 heritable variation 50 atopy 50 ACOG guidelines 50 severely cognitively impaired 50 gene expression Sapienza 50 Insulin sensitivity 50 breast cancer susceptibility genes 50 seroprotection 50 metabolizers 50 Cesarean deliveries 50 KRAS mutations occur